Lynn A. Fussner

1.2k total citations
31 papers, 711 citations indexed

About

Lynn A. Fussner is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Genetics. According to data from OpenAlex, Lynn A. Fussner has authored 31 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 11 papers in Genetics. Recurrent topics in Lynn A. Fussner's work include Vasculitis and related conditions (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (5 papers). Lynn A. Fussner is often cited by papers focused on Vasculitis and related conditions (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (5 papers). Lynn A. Fussner collaborates with scholars based in United States, United Kingdom and Netherlands. Lynn A. Fussner's co-authors include Marianna Sockrider, Kymberly D. Watt, Chun Fan, Elizabeth Coss, Ross Dierkhising, Julie K. Heimbach, David Jayne, Michael D. Leise, Alexa Meara and Sergey V. Brodsky and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Frontiers in Immunology.

In The Last Decade

Lynn A. Fussner

26 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn A. Fussner United States 11 377 206 190 175 145 31 711
Mirella Alpa Italy 18 262 0.7× 145 0.7× 187 1.0× 71 0.4× 106 0.7× 28 1.1k
Y. Schoindre France 10 259 0.7× 102 0.5× 120 0.6× 31 0.2× 154 1.1× 25 733
Joost C. M. Meijers Netherlands 9 287 0.8× 135 0.7× 121 0.6× 51 0.3× 185 1.3× 9 826
Xavier Belenfant France 11 319 0.8× 79 0.4× 31 0.2× 180 1.0× 87 0.6× 27 740
Martin Doelberg Switzerland 10 793 2.1× 132 0.6× 42 0.2× 27 0.2× 127 0.9× 15 1.2k
İbrahim Hatemı Türkiye 15 171 0.5× 141 0.7× 88 0.5× 48 0.3× 286 2.0× 78 720
I. Bruce Elfenbein United States 10 143 0.4× 165 0.8× 123 0.6× 156 0.9× 156 1.1× 21 696
Döndü Üsküdar Cansu Türkiye 13 124 0.3× 82 0.4× 62 0.3× 36 0.2× 89 0.6× 86 650
Fernando Nolasco Portugal 12 147 0.4× 126 0.6× 73 0.4× 26 0.1× 103 0.7× 88 831
Konstantinos Revenas Greece 10 227 0.6× 86 0.4× 32 0.2× 54 0.3× 116 0.8× 26 469

Countries citing papers authored by Lynn A. Fussner

Since Specialization
Citations

This map shows the geographic impact of Lynn A. Fussner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn A. Fussner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn A. Fussner more than expected).

Fields of papers citing papers by Lynn A. Fussner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn A. Fussner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn A. Fussner. The network helps show where Lynn A. Fussner may publish in the future.

Co-authorship network of co-authors of Lynn A. Fussner

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn A. Fussner. A scholar is included among the top collaborators of Lynn A. Fussner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn A. Fussner. Lynn A. Fussner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Songzhu, Lai Wei, Joshua A. Englert, et al.. (2025). Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis. Cancer Immunology Immunotherapy. 74(2). 46–46.
2.
Specks, Ulrich, Robert Spiera, Lynn A. Fussner, et al.. (2025). Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. ACR Open Rheumatology. 7(1). e11795–e11795. 4 indexed citations
3.
Eisner, Mariah, et al.. (2024). Diffuse alveolar hemorrhage in pediatrics: Etiologies and outcomes. Pediatric Pulmonology. 59(12). 3364–3370. 1 indexed citations
4.
Fussner, Lynn A., Henry D. Tazelaar, Erin K. O’Brien, et al.. (2024). Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis. The Lancet Rheumatology. 6(5). e314–e327. 12 indexed citations
5.
Fussner, Lynn A., et al.. (2024). Interleukin-5 Antagonist Monoclonal Antibody Therapy Improves Symptoms and Reduces Steroid Dependence in Eosinophilic Myocarditis Patients. JACC Case Reports. 29(7). 102267–102267. 5 indexed citations
6.
Fussner, Lynn A., Luis Felipe Flores-Suárez, Rodrigo Cartin‐Ceba, et al.. (2024). Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS). American Journal of Respiratory and Critical Care Medicine. 209(9). 1141–1151. 13 indexed citations
7.
Fussner, Lynn A., Jim J. Aloor, Sky W. Reece, et al.. (2023). The prohibitin complex regulates macrophage fatty acid composition, plasma membrane packing, and lipid raft-mediated inflammatory signaling. Prostaglandins Leukotrienes and Essential Fatty Acids. 190. 102540–102540. 6 indexed citations
8.
Wong, Alexander, Xueliang Pan, Salem Almaani, et al.. (2023). Impact of concurrent glomerulonephritis on outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis. Clinical and Experimental Rheumatology. 42(4). 811–815. 1 indexed citations
9.
Mikacenic, Carmen, Lynn A. Fussner, Ellen L. Burnham, et al.. (2023). Research Bronchoscopies in Critically Ill Research Participants: An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society. 20(5). 621–631. 4 indexed citations
10.
Moura, Marta Casal, Darlene R. Nelson, Lynn A. Fussner, et al.. (2022). Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3. Arthritis & Rheumatology. 75(5). 748–759. 1 indexed citations
11.
Collister, David, Paul Brown, Alfred Mahr, et al.. (2022). Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient Preferences. Kidney Medicine. 5(3). 100595–100595. 8 indexed citations
12.
Almaani, Salem, Lynn A. Fussner, Sergey V. Brodsky, Alexa Meara, & David Jayne. (2021). ANCA-Associated Vasculitis: An Update. Journal of Clinical Medicine. 10(7). 1446–1446. 96 indexed citations
13.
Fussner, Lynn A., Carmen Mikacenic, Tamás Dolinay, & Benjamin T. Suratt. (2020). How Is Asthma Treated?. American Journal of Respiratory and Critical Care Medicine. 202(3). P9–P10.
14.
Sockrider, Marianna & Lynn A. Fussner. (2020). What Is Asthma?. American Journal of Respiratory and Critical Care Medicine. 202(9). P25–P26. 92 indexed citations
15.
Doyle, Sarah, et al.. (2020). Massive Hemoptysis Secondary to a Rare Bronchial Artery to Pulmonary Artery Fistula. A6797–A6797. 1 indexed citations
16.
Fussner, Lynn A., Amber M. Hummel, Darrell R. Schroeder, et al.. (2020). Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis. Frontiers in Immunology. 11. 2053–2053. 14 indexed citations
17.
Bazan, José A., et al.. (2019). Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem. International Journal of Antimicrobial Agents. 54(6). 824–828. 3 indexed citations
18.
Fussner, Lynn A., David O. Hodge, Nowell M. Fine, et al.. (2018). Management and Outcomes of Cardiac Sarcoidosis: A 20-Year Experience in Two Tertiary Care Centres. European Journal of Heart Failure. 20(12). 1713–1720. 67 indexed citations
19.
Fussner, Lynn A., et al.. (2016). 46-Year-Old Man With Jaundice and Hypoxemia. Mayo Clinic Proceedings. 91(12). 1834–1839. 1 indexed citations
20.
Fussner, Lynn A. & Ulrich Specks. (2015). Can antineutrophil cytoplasmic antibody levels be used to inform treatment of pauci-immune vasculitis?. Current Opinion in Rheumatology. 27(3). 231–240. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirella Alpa Breakdown of academic impact, for papers by Y. Schoindre Breakdown of academic impact, for papers by Joost C. M. Meijers Breakdown of academic impact, for papers by Xavier Belenfant Breakdown of academic impact, for papers by Martin Doelberg Breakdown of academic impact, for papers by İbrahim Hatemı Breakdown of academic impact, for papers by I. Bruce Elfenbein Breakdown of academic impact, for papers by Döndü Üsküdar Cansu Breakdown of academic impact, for papers by Fernando Nolasco Breakdown of academic impact, for papers by Konstantinos Revenas
Rankless by CCL
2026